Dr. DeRosier is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Covance, Inc
Raleigh
Raleigh, NC 27614Phone+1 984-218-0142
Summary
- More than 10 years of private practice experience (internal medicine) and nearly 19 years of clinical development experience in the pharmaceutical industry, primarily in neurosciences and rare diseases as global lead physician or program-level physician across multiple indications, and providing expertise on medical strategy, project feasibility and risk assessment and program execution.
Education & Training
- University of ConnecticutResidency, Internal Medicine, 1988 - 1991
- St Clares Hospital Health CenterInternship, Preliminary Year, 1987 - 1988
- NYIT College Of Osteopathic MedicineClass of 1987
Certifications & Licensure
- CT State License 1989 - 2025
Publications & Presentations
PubMed
- 175 citationsSafety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 studyPer Soelberg Sørensen, Steen Lisby, Richard Grove, Frederick J. Derosier, Steve Shackelford
Neurology. 2014-02-18 - 17 citationsSumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover studyFrederick J. Derosier, Fred D. Sheftell, Stephen D. Silberstein, Roger Cady, Gary E. Ruoff
Headache. 2012-04-01 - 110 citationsSubcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.Amit Bar-Or, Richard A. Grove, Daren Austin, Jerry M. Tolson, Susan A. VanMeter
Neurology. 2018-05-15
Other
- Development of ISIS-TTRRx for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)Frederick Derosier, Jesse Kwon, Elizabeth Ackerman, Erin Lettow, Mason Yamashita, Steven Hughes, Brett Monia, Neurology 84 (14 Supplement) 2015
http://n.neurology.org/content/84/14_Supplement/S34.009
Washington, DC - 4/22/2015
Professional Memberships
- American Academy of NeurologyMember
Industry Relationships
- Executive Director, Clinical Sciences, Alexion Pharmaceuticals2015 - 2017
- Executive Director, Clinical Development, Ionis Pharmaceuticals2014 - 2015
- Executive Director, Neurosciences, Merz Pharmaceuticals2013 - 2014
- Director, Neurosciences, GlaxoSmithKline2002 - 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: